Views & Analysis Web and mobile technologies for health economics modelling Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
Views & Analysis Patient-centric trials – dream or reality? Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?
Views & Analysis Collaboration the key to success in respiratory research Lung research needs support as fifth of UK diagnosed with respiratory condition.
Views & Analysis Access and elimination: the future of DAAs in hepatitis C How direct-acting antivirals are transforming treatment of hepatitis C.
News UK science funding uncertain after Brexit vote UK government says funding will continue until Brexit is resolved.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.